Delivery Order SPE2DB20D2001-SPE2DB24FM51H
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $48,505.54 firm fixed-price contract is for the supply of Ozempic 0.25-0.5 mg/dose pens. It has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $15,799.93 firm fixed-price contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens to support military healthcare programs. The contract has an ultimate completion date of December 31, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide Ozempic 0.25-0.5 mg/dose pens. The $2,860.16 firm fixed-price contract has an ultimate completion date of April 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has a ceiling value of $1,879.98 and a period of performance through March 18, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is valued at $4,042.58 and is for the pharmaceutical product Ozempic (0.25-0.5 mg/dose pen, 3 mL). The contract has a firm fixed price pricing type and a completion date of July 9, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ozempic 0.25-0.5 mg/dose pens. The $1,338.55 firm fixed price contract has a July 2023 completion date and is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The contract has a ceiling value of $4,888.26 and is a firm fixed price contract. The ultimate completion date is August 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a...
- This is a $2,855.60 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen, 3 ml, with a performance period through February 14, 2024. Amerisourcebergen is an established medical supply distributor with a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Ozempic 0.25-0.5 mg/dose pens. The $3,643.56 firm fixed-price contract has an ultimate completion date of April 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,795.43 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml, a medication used for diabetes management. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB24FM51HDelivery Order
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,932.22 firm fixed price contract is for the delivery of the drug Ozempic in the 0.25-0.5 mg/dose 3 mL pen form. The ultimate completion date is March 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 3/22/24 |